Page last updated: 2024-10-30

loratadine and Aggressive Systemic Mastocytosis

loratadine has been researched along with Aggressive Systemic Mastocytosis in 1 studies

Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.

Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hadzijusufovic, E1
Peter, B1
Gleixner, KV1
Schuch, K1
Pickl, WF1
Thaiwong, T1
Yuzbasiyan-Gurkan, V1
Mirkina, I1
Willmann, M1
Valent, P1

Other Studies

1 other study available for loratadine and Aggressive Systemic Mastocytosis

ArticleYear
H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells.
    Experimental hematology, 2010, Volume: 38, Issue:10

    Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cats; Cell Line, Tumor; Cell Proliferation; Dasati

2010